nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—chronic kidney failure—Cholecalciferol—ulcerative colitis	0.537	1	CpDpCtD
Deferoxamine—XDH—Azathioprine—ulcerative colitis	0.193	0.5	CbGbCtD
Deferoxamine—XDH—Mercaptopurine—ulcerative colitis	0.193	0.5	CbGbCtD
Deferoxamine—Infection—Mesalazine—ulcerative colitis	0.000119	0.00155	CcSEcCtD
Deferoxamine—Visual impairment—Prednisolone—ulcerative colitis	0.000118	0.00154	CcSEcCtD
Deferoxamine—Shock—Mesalazine—ulcerative colitis	0.000117	0.00153	CcSEcCtD
Deferoxamine—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000117	0.00153	CcSEcCtD
Deferoxamine—Nervous system disorder—Mesalazine—ulcerative colitis	0.000117	0.00153	CcSEcCtD
Deferoxamine—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000117	0.00152	CcSEcCtD
Deferoxamine—Urticaria—Budesonide—ulcerative colitis	0.000117	0.00152	CcSEcCtD
Deferoxamine—Tachycardia—Mesalazine—ulcerative colitis	0.000117	0.00152	CcSEcCtD
Deferoxamine—Body temperature increased—Budesonide—ulcerative colitis	0.000116	0.00151	CcSEcCtD
Deferoxamine—Abdominal pain—Budesonide—ulcerative colitis	0.000116	0.00151	CcSEcCtD
Deferoxamine—Skin disorder—Mesalazine—ulcerative colitis	0.000116	0.00151	CcSEcCtD
Deferoxamine—Bradycardia—Triamcinolone—ulcerative colitis	0.000115	0.00149	CcSEcCtD
Deferoxamine—Bradycardia—Methylprednisolone—ulcerative colitis	0.000114	0.00149	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000113	0.00148	CcSEcCtD
Deferoxamine—Hallucination—Methylprednisolone—ulcerative colitis	0.000112	0.00146	CcSEcCtD
Deferoxamine—Eye disorder—Hydrocortisone—ulcerative colitis	0.000112	0.00146	CcSEcCtD
Deferoxamine—Hypotension—Mesalazine—ulcerative colitis	0.000112	0.00145	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000111	0.00145	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000111	0.00145	CcSEcCtD
Deferoxamine—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.00011	0.00144	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisolone—ulcerative colitis	0.000109	0.00143	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000109	0.00142	CcSEcCtD
Deferoxamine—Visual impairment—Methylprednisolone—ulcerative colitis	0.000108	0.00141	CcSEcCtD
Deferoxamine—Hypersensitivity—Budesonide—ulcerative colitis	0.000108	0.00141	CcSEcCtD
Deferoxamine—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000108	0.00141	CcSEcCtD
Deferoxamine—Paraesthesia—Mesalazine—ulcerative colitis	0.000107	0.0014	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000107	0.0014	CcSEcCtD
Deferoxamine—Arrhythmia—Hydrocortisone—ulcerative colitis	0.000107	0.00139	CcSEcCtD
Deferoxamine—Erythema—Prednisolone—ulcerative colitis	0.000107	0.00139	CcSEcCtD
Deferoxamine—Dyspnoea—Mesalazine—ulcerative colitis	0.000106	0.00139	CcSEcCtD
Deferoxamine—Eye disorder—Methylprednisolone—ulcerative colitis	0.000105	0.00137	CcSEcCtD
Deferoxamine—Erythema—Hydrocortisone—ulcerative colitis	0.000104	0.00136	CcSEcCtD
Deferoxamine—Bradycardia—Dexamethasone—ulcerative colitis	0.000104	0.00136	CcSEcCtD
Deferoxamine—Bradycardia—Betamethasone—ulcerative colitis	0.000104	0.00136	CcSEcCtD
Deferoxamine—Pruritus—Budesonide—ulcerative colitis	0.000104	0.00135	CcSEcCtD
Deferoxamine—Abdominal pain—Azathioprine—ulcerative colitis	0.000104	0.00135	CcSEcCtD
Deferoxamine—Body temperature increased—Azathioprine—ulcerative colitis	0.000104	0.00135	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000103	0.00134	CcSEcCtD
Deferoxamine—Pain—Mesalazine—ulcerative colitis	0.000102	0.00133	CcSEcCtD
Deferoxamine—Angiopathy—Methylprednisolone—ulcerative colitis	0.000102	0.00133	CcSEcCtD
Deferoxamine—Hallucination—Betamethasone—ulcerative colitis	0.000102	0.00132	CcSEcCtD
Deferoxamine—Hallucination—Dexamethasone—ulcerative colitis	0.000102	0.00132	CcSEcCtD
Deferoxamine—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000101	0.00132	CcSEcCtD
Deferoxamine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000101	0.00132	CcSEcCtD
Deferoxamine—Arrhythmia—Triamcinolone—ulcerative colitis	0.000101	0.00131	CcSEcCtD
Deferoxamine—Diarrhoea—Budesonide—ulcerative colitis	0.0001	0.00131	CcSEcCtD
Deferoxamine—Vision blurred—Prednisolone—ulcerative colitis	0.0001	0.00131	CcSEcCtD
Deferoxamine—Arrhythmia—Methylprednisolone—ulcerative colitis	0.0001	0.00131	CcSEcCtD
Deferoxamine—Visual impairment—Dexamethasone—ulcerative colitis	9.84e-05	0.00128	CcSEcCtD
Deferoxamine—Visual impairment—Betamethasone—ulcerative colitis	9.84e-05	0.00128	CcSEcCtD
Deferoxamine—Erythema—Triamcinolone—ulcerative colitis	9.8e-05	0.00128	CcSEcCtD
Deferoxamine—Erythema—Methylprednisolone—ulcerative colitis	9.77e-05	0.00127	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Mesalazine—ulcerative colitis	9.76e-05	0.00127	CcSEcCtD
Deferoxamine—Angioedema—Prednisolone—ulcerative colitis	9.73e-05	0.00127	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Prednisone—ulcerative colitis	9.71e-05	0.00127	CcSEcCtD
Deferoxamine—Dizziness—Budesonide—ulcerative colitis	9.71e-05	0.00127	CcSEcCtD
Deferoxamine—Hypersensitivity—Azathioprine—ulcerative colitis	9.66e-05	0.00126	CcSEcCtD
Deferoxamine—Eye disorder—Dexamethasone—ulcerative colitis	9.54e-05	0.00124	CcSEcCtD
Deferoxamine—Eye disorder—Betamethasone—ulcerative colitis	9.54e-05	0.00124	CcSEcCtD
Deferoxamine—Angioedema—Hydrocortisone—ulcerative colitis	9.51e-05	0.00124	CcSEcCtD
Deferoxamine—Urticaria—Mesalazine—ulcerative colitis	9.49e-05	0.00124	CcSEcCtD
Deferoxamine—Abdominal pain—Mesalazine—ulcerative colitis	9.44e-05	0.00123	CcSEcCtD
Deferoxamine—Body temperature increased—Mesalazine—ulcerative colitis	9.44e-05	0.00123	CcSEcCtD
Deferoxamine—Vomiting—Budesonide—ulcerative colitis	9.34e-05	0.00122	CcSEcCtD
Deferoxamine—Angiopathy—Betamethasone—ulcerative colitis	9.26e-05	0.00121	CcSEcCtD
Deferoxamine—Angiopathy—Dexamethasone—ulcerative colitis	9.26e-05	0.00121	CcSEcCtD
Deferoxamine—Convulsion—Prednisolone—ulcerative colitis	9.23e-05	0.0012	CcSEcCtD
Deferoxamine—Headache—Budesonide—ulcerative colitis	9.2e-05	0.0012	CcSEcCtD
Deferoxamine—Arrhythmia—Dexamethasone—ulcerative colitis	9.12e-05	0.00119	CcSEcCtD
Deferoxamine—Arrhythmia—Betamethasone—ulcerative colitis	9.12e-05	0.00119	CcSEcCtD
Deferoxamine—Bradycardia—Prednisone—ulcerative colitis	9.05e-05	0.00118	CcSEcCtD
Deferoxamine—Convulsion—Hydrocortisone—ulcerative colitis	9.01e-05	0.00118	CcSEcCtD
Deferoxamine—Diarrhoea—Azathioprine—ulcerative colitis	8.97e-05	0.00117	CcSEcCtD
Deferoxamine—Angioedema—Triamcinolone—ulcerative colitis	8.95e-05	0.00117	CcSEcCtD
Deferoxamine—Angioedema—Methylprednisolone—ulcerative colitis	8.93e-05	0.00116	CcSEcCtD
Deferoxamine—Erythema—Dexamethasone—ulcerative colitis	8.89e-05	0.00116	CcSEcCtD
Deferoxamine—Erythema—Betamethasone—ulcerative colitis	8.89e-05	0.00116	CcSEcCtD
Deferoxamine—Myalgia—Hydrocortisone—ulcerative colitis	8.86e-05	0.00115	CcSEcCtD
Deferoxamine—Hallucination—Prednisone—ulcerative colitis	8.85e-05	0.00115	CcSEcCtD
Deferoxamine—Hypersensitivity—Mesalazine—ulcerative colitis	8.8e-05	0.00115	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	8.8e-05	0.00115	CcSEcCtD
Deferoxamine—Connective tissue disorder—Prednisone—ulcerative colitis	8.74e-05	0.00114	CcSEcCtD
Deferoxamine—Nausea—Budesonide—ulcerative colitis	8.72e-05	0.00114	CcSEcCtD
Deferoxamine—Oedema—Prednisolone—ulcerative colitis	8.69e-05	0.00113	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisolone—ulcerative colitis	8.69e-05	0.00113	CcSEcCtD
Deferoxamine—Dizziness—Azathioprine—ulcerative colitis	8.67e-05	0.00113	CcSEcCtD
Deferoxamine—Shock—Prednisolone—ulcerative colitis	8.55e-05	0.00112	CcSEcCtD
Deferoxamine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	8.49e-05	0.00111	CcSEcCtD
Deferoxamine—Oedema—Hydrocortisone—ulcerative colitis	8.49e-05	0.00111	CcSEcCtD
Deferoxamine—Convulsion—Triamcinolone—ulcerative colitis	8.49e-05	0.00111	CcSEcCtD
Deferoxamine—Tachycardia—Prednisolone—ulcerative colitis	8.49e-05	0.00111	CcSEcCtD
Deferoxamine—Convulsion—Methylprednisolone—ulcerative colitis	8.47e-05	0.0011	CcSEcCtD
Deferoxamine—Pruritus—Mesalazine—ulcerative colitis	8.45e-05	0.0011	CcSEcCtD
Deferoxamine—Infection—Hydrocortisone—ulcerative colitis	8.44e-05	0.0011	CcSEcCtD
Deferoxamine—Shock—Hydrocortisone—ulcerative colitis	8.35e-05	0.00109	CcSEcCtD
Deferoxamine—Myalgia—Triamcinolone—ulcerative colitis	8.34e-05	0.00109	CcSEcCtD
Deferoxamine—Vomiting—Azathioprine—ulcerative colitis	8.34e-05	0.00109	CcSEcCtD
Deferoxamine—Nervous system disorder—Hydrocortisone—ulcerative colitis	8.33e-05	0.00109	CcSEcCtD
Deferoxamine—Myalgia—Methylprednisolone—ulcerative colitis	8.32e-05	0.00108	CcSEcCtD
Deferoxamine—Arthralgia—Methylprednisolone—ulcerative colitis	8.32e-05	0.00108	CcSEcCtD
Deferoxamine—Eye disorder—Prednisone—ulcerative colitis	8.31e-05	0.00108	CcSEcCtD
Deferoxamine—Tachycardia—Hydrocortisone—ulcerative colitis	8.29e-05	0.00108	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	8.26e-05	0.00108	CcSEcCtD
Deferoxamine—Skin disorder—Hydrocortisone—ulcerative colitis	8.25e-05	0.00108	CcSEcCtD
Deferoxamine—Headache—Azathioprine—ulcerative colitis	8.21e-05	0.00107	CcSEcCtD
Deferoxamine—Diarrhoea—Mesalazine—ulcerative colitis	8.17e-05	0.00107	CcSEcCtD
Deferoxamine—Angioedema—Dexamethasone—ulcerative colitis	8.12e-05	0.00106	CcSEcCtD
Deferoxamine—Angioedema—Betamethasone—ulcerative colitis	8.12e-05	0.00106	CcSEcCtD
Deferoxamine—Angiopathy—Prednisone—ulcerative colitis	8.07e-05	0.00105	CcSEcCtD
Deferoxamine—Immune system disorder—Prednisone—ulcerative colitis	8.03e-05	0.00105	CcSEcCtD
Deferoxamine—Anaphylactic shock—Triamcinolone—ulcerative colitis	8e-05	0.00104	CcSEcCtD
Deferoxamine—Oedema—Triamcinolone—ulcerative colitis	8e-05	0.00104	CcSEcCtD
Deferoxamine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	7.98e-05	0.00104	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisone—ulcerative colitis	7.94e-05	0.00104	CcSEcCtD
Deferoxamine—Infection—Triamcinolone—ulcerative colitis	7.94e-05	0.00104	CcSEcCtD
Deferoxamine—Hypotension—Hydrocortisone—ulcerative colitis	7.93e-05	0.00103	CcSEcCtD
Deferoxamine—Infection—Methylprednisolone—ulcerative colitis	7.93e-05	0.00103	CcSEcCtD
Deferoxamine—Dizziness—Mesalazine—ulcerative colitis	7.9e-05	0.00103	CcSEcCtD
Deferoxamine—Shock—Triamcinolone—ulcerative colitis	7.87e-05	0.00103	CcSEcCtD
Deferoxamine—Shock—Methylprednisolone—ulcerative colitis	7.85e-05	0.00102	CcSEcCtD
Deferoxamine—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.82e-05	0.00102	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisolone—ulcerative colitis	7.81e-05	0.00102	CcSEcCtD
Deferoxamine—Tachycardia—Triamcinolone—ulcerative colitis	7.8e-05	0.00102	CcSEcCtD
Deferoxamine—Nausea—Azathioprine—ulcerative colitis	7.79e-05	0.00102	CcSEcCtD
Deferoxamine—Tachycardia—Methylprednisolone—ulcerative colitis	7.79e-05	0.00101	CcSEcCtD
Deferoxamine—Skin disorder—Methylprednisolone—ulcerative colitis	7.75e-05	0.00101	CcSEcCtD
Deferoxamine—Erythema—Prednisone—ulcerative colitis	7.74e-05	0.00101	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.74e-05	0.00101	CcSEcCtD
Deferoxamine—Convulsion—Dexamethasone—ulcerative colitis	7.7e-05	0.001	CcSEcCtD
Deferoxamine—Convulsion—Betamethasone—ulcerative colitis	7.7e-05	0.001	CcSEcCtD
Deferoxamine—Paraesthesia—Hydrocortisone—ulcerative colitis	7.62e-05	0.000994	CcSEcCtD
Deferoxamine—Vomiting—Mesalazine—ulcerative colitis	7.59e-05	0.00099	CcSEcCtD
Deferoxamine—Myalgia—Dexamethasone—ulcerative colitis	7.57e-05	0.000987	CcSEcCtD
Deferoxamine—Myalgia—Betamethasone—ulcerative colitis	7.57e-05	0.000987	CcSEcCtD
Deferoxamine—Headache—Mesalazine—ulcerative colitis	7.48e-05	0.000975	CcSEcCtD
Deferoxamine—Hypotension—Methylprednisolone—ulcerative colitis	7.45e-05	0.000972	CcSEcCtD
Deferoxamine—Pain—Prednisolone—ulcerative colitis	7.43e-05	0.000969	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	7.33e-05	0.000956	CcSEcCtD
Deferoxamine—Vision blurred—Prednisone—ulcerative colitis	7.3e-05	0.000951	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.28e-05	0.00095	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.27e-05	0.000947	CcSEcCtD
Deferoxamine—Pain—Hydrocortisone—ulcerative colitis	7.26e-05	0.000947	CcSEcCtD
Deferoxamine—Anaphylactic shock—Betamethasone—ulcerative colitis	7.25e-05	0.000946	CcSEcCtD
Deferoxamine—Oedema—Betamethasone—ulcerative colitis	7.25e-05	0.000946	CcSEcCtD
Deferoxamine—Anaphylactic shock—Dexamethasone—ulcerative colitis	7.25e-05	0.000946	CcSEcCtD
Deferoxamine—Oedema—Dexamethasone—ulcerative colitis	7.25e-05	0.000946	CcSEcCtD
Deferoxamine—Infection—Betamethasone—ulcerative colitis	7.21e-05	0.00094	CcSEcCtD
Deferoxamine—Infection—Dexamethasone—ulcerative colitis	7.21e-05	0.00094	CcSEcCtD
Deferoxamine—Paraesthesia—Triamcinolone—ulcerative colitis	7.18e-05	0.000936	CcSEcCtD
Deferoxamine—Paraesthesia—Methylprednisolone—ulcerative colitis	7.16e-05	0.000934	CcSEcCtD
Deferoxamine—Shock—Dexamethasone—ulcerative colitis	7.14e-05	0.00093	CcSEcCtD
Deferoxamine—Shock—Betamethasone—ulcerative colitis	7.14e-05	0.00093	CcSEcCtD
Deferoxamine—Dyspnoea—Triamcinolone—ulcerative colitis	7.13e-05	0.000929	CcSEcCtD
Deferoxamine—Nervous system disorder—Betamethasone—ulcerative colitis	7.11e-05	0.000927	CcSEcCtD
Deferoxamine—Nervous system disorder—Dexamethasone—ulcerative colitis	7.11e-05	0.000927	CcSEcCtD
Deferoxamine—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.1e-05	0.000926	CcSEcCtD
Deferoxamine—Thrombocytopenia—Betamethasone—ulcerative colitis	7.1e-05	0.000926	CcSEcCtD
Deferoxamine—Nausea—Mesalazine—ulcerative colitis	7.09e-05	0.000925	CcSEcCtD
Deferoxamine—Tachycardia—Dexamethasone—ulcerative colitis	7.08e-05	0.000923	CcSEcCtD
Deferoxamine—Tachycardia—Betamethasone—ulcerative colitis	7.08e-05	0.000923	CcSEcCtD
Deferoxamine—Angioedema—Prednisone—ulcerative colitis	7.07e-05	0.000922	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.94e-05	0.000905	CcSEcCtD
Deferoxamine—Urticaria—Prednisolone—ulcerative colitis	6.91e-05	0.0009	CcSEcCtD
Deferoxamine—Pain—Triamcinolone—ulcerative colitis	6.84e-05	0.000891	CcSEcCtD
Deferoxamine—Hypotension—Betamethasone—ulcerative colitis	6.78e-05	0.000884	CcSEcCtD
Deferoxamine—Hypotension—Dexamethasone—ulcerative colitis	6.78e-05	0.000884	CcSEcCtD
Deferoxamine—Urticaria—Hydrocortisone—ulcerative colitis	6.75e-05	0.000879	CcSEcCtD
Deferoxamine—Abdominal pain—Hydrocortisone—ulcerative colitis	6.71e-05	0.000875	CcSEcCtD
Deferoxamine—Body temperature increased—Hydrocortisone—ulcerative colitis	6.71e-05	0.000875	CcSEcCtD
Deferoxamine—Convulsion—Prednisone—ulcerative colitis	6.71e-05	0.000874	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.61e-05	0.000862	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.61e-05	0.000862	CcSEcCtD
Deferoxamine—Myalgia—Prednisone—ulcerative colitis	6.59e-05	0.000859	CcSEcCtD
Deferoxamine—Arthralgia—Prednisone—ulcerative colitis	6.59e-05	0.000859	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.55e-05	0.000853	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.52e-05	0.00085	CcSEcCtD
Deferoxamine—Paraesthesia—Betamethasone—ulcerative colitis	6.51e-05	0.000849	CcSEcCtD
Deferoxamine—Paraesthesia—Dexamethasone—ulcerative colitis	6.51e-05	0.000849	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisolone—ulcerative colitis	6.41e-05	0.000835	CcSEcCtD
Deferoxamine—Urticaria—Triamcinolone—ulcerative colitis	6.35e-05	0.000828	CcSEcCtD
Deferoxamine—Urticaria—Methylprednisolone—ulcerative colitis	6.34e-05	0.000826	CcSEcCtD
Deferoxamine—Body temperature increased—Triamcinolone—ulcerative colitis	6.32e-05	0.000824	CcSEcCtD
Deferoxamine—Oedema—Prednisone—ulcerative colitis	6.32e-05	0.000824	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisone—ulcerative colitis	6.32e-05	0.000824	CcSEcCtD
Deferoxamine—Abdominal pain—Methylprednisolone—ulcerative colitis	6.31e-05	0.000822	CcSEcCtD
Deferoxamine—Infection—Prednisone—ulcerative colitis	6.28e-05	0.000818	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	6.26e-05	0.000816	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	6.26e-05	0.000816	CcSEcCtD
Deferoxamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.26e-05	0.000816	CcSEcCtD
Deferoxamine—Shock—Prednisone—ulcerative colitis	6.22e-05	0.00081	CcSEcCtD
Deferoxamine—Pain—Dexamethasone—ulcerative colitis	6.2e-05	0.000809	CcSEcCtD
Deferoxamine—Pain—Betamethasone—ulcerative colitis	6.2e-05	0.000809	CcSEcCtD
Deferoxamine—Nervous system disorder—Prednisone—ulcerative colitis	6.2e-05	0.000808	CcSEcCtD
Deferoxamine—Tachycardia—Prednisone—ulcerative colitis	6.17e-05	0.000804	CcSEcCtD
Deferoxamine—Skin disorder—Prednisone—ulcerative colitis	6.14e-05	0.0008	CcSEcCtD
Deferoxamine—Pruritus—Hydrocortisone—ulcerative colitis	6.01e-05	0.000783	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.93e-05	0.000773	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.93e-05	0.000773	CcSEcCtD
Deferoxamine—Hypersensitivity—Triamcinolone—ulcerative colitis	5.89e-05	0.000768	CcSEcCtD
Deferoxamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.88e-05	0.000766	CcSEcCtD
Deferoxamine—Diarrhoea—Hydrocortisone—ulcerative colitis	5.81e-05	0.000757	CcSEcCtD
Deferoxamine—Urticaria—Dexamethasone—ulcerative colitis	5.76e-05	0.000751	CcSEcCtD
Deferoxamine—Urticaria—Betamethasone—ulcerative colitis	5.76e-05	0.000751	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.76e-05	0.00075	CcSEcCtD
Deferoxamine—Dizziness—Prednisolone—ulcerative colitis	5.75e-05	0.000749	CcSEcCtD
Deferoxamine—Body temperature increased—Dexamethasone—ulcerative colitis	5.73e-05	0.000748	CcSEcCtD
Deferoxamine—Abdominal pain—Dexamethasone—ulcerative colitis	5.73e-05	0.000748	CcSEcCtD
Deferoxamine—Body temperature increased—Betamethasone—ulcerative colitis	5.73e-05	0.000748	CcSEcCtD
Deferoxamine—Abdominal pain—Betamethasone—ulcerative colitis	5.73e-05	0.000748	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisone—ulcerative colitis	5.67e-05	0.00074	CcSEcCtD
Deferoxamine—Pruritus—Triamcinolone—ulcerative colitis	5.66e-05	0.000737	CcSEcCtD
Deferoxamine—Pruritus—Methylprednisolone—ulcerative colitis	5.64e-05	0.000736	CcSEcCtD
Deferoxamine—Dizziness—Hydrocortisone—ulcerative colitis	5.62e-05	0.000732	CcSEcCtD
Deferoxamine—Diarrhoea—Methylprednisolone—ulcerative colitis	5.46e-05	0.000712	CcSEcCtD
Deferoxamine—Headache—Prednisolone—ulcerative colitis	5.45e-05	0.00071	CcSEcCtD
Deferoxamine—Vomiting—Hydrocortisone—ulcerative colitis	5.4e-05	0.000704	CcSEcCtD
Deferoxamine—Headache—Hydrocortisone—ulcerative colitis	5.32e-05	0.000693	CcSEcCtD
Deferoxamine—Dizziness—Triamcinolone—ulcerative colitis	5.29e-05	0.000689	CcSEcCtD
Deferoxamine—Dizziness—Methylprednisolone—ulcerative colitis	5.28e-05	0.000688	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Prednisone—ulcerative colitis	5.17e-05	0.000673	CcSEcCtD
Deferoxamine—Nausea—Prednisolone—ulcerative colitis	5.16e-05	0.000673	CcSEcCtD
Deferoxamine—Pruritus—Dexamethasone—ulcerative colitis	5.13e-05	0.000669	CcSEcCtD
Deferoxamine—Pruritus—Betamethasone—ulcerative colitis	5.13e-05	0.000669	CcSEcCtD
Deferoxamine—Vomiting—Triamcinolone—ulcerative colitis	5.08e-05	0.000663	CcSEcCtD
Deferoxamine—Vomiting—Methylprednisolone—ulcerative colitis	5.07e-05	0.000661	CcSEcCtD
Deferoxamine—Nausea—Hydrocortisone—ulcerative colitis	5.04e-05	0.000658	CcSEcCtD
Deferoxamine—Urticaria—Prednisone—ulcerative colitis	5.02e-05	0.000654	CcSEcCtD
Deferoxamine—Headache—Triamcinolone—ulcerative colitis	5.01e-05	0.000653	CcSEcCtD
Deferoxamine—Headache—Methylprednisolone—ulcerative colitis	5e-05	0.000652	CcSEcCtD
Deferoxamine—Abdominal pain—Prednisone—ulcerative colitis	4.99e-05	0.000651	CcSEcCtD
Deferoxamine—Body temperature increased—Prednisone—ulcerative colitis	4.99e-05	0.000651	CcSEcCtD
Deferoxamine—Diarrhoea—Dexamethasone—ulcerative colitis	4.96e-05	0.000647	CcSEcCtD
Deferoxamine—Diarrhoea—Betamethasone—ulcerative colitis	4.96e-05	0.000647	CcSEcCtD
Deferoxamine—Dizziness—Betamethasone—ulcerative colitis	4.8e-05	0.000625	CcSEcCtD
Deferoxamine—Dizziness—Dexamethasone—ulcerative colitis	4.8e-05	0.000625	CcSEcCtD
Deferoxamine—Nausea—Triamcinolone—ulcerative colitis	4.75e-05	0.000619	CcSEcCtD
Deferoxamine—Nausea—Methylprednisolone—ulcerative colitis	4.74e-05	0.000618	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisone—ulcerative colitis	4.65e-05	0.000607	CcSEcCtD
Deferoxamine—Vomiting—Dexamethasone—ulcerative colitis	4.61e-05	0.000601	CcSEcCtD
Deferoxamine—Vomiting—Betamethasone—ulcerative colitis	4.61e-05	0.000601	CcSEcCtD
Deferoxamine—Headache—Dexamethasone—ulcerative colitis	4.54e-05	0.000592	CcSEcCtD
Deferoxamine—Headache—Betamethasone—ulcerative colitis	4.54e-05	0.000592	CcSEcCtD
Deferoxamine—Pruritus—Prednisone—ulcerative colitis	4.47e-05	0.000583	CcSEcCtD
Deferoxamine—Diarrhoea—Prednisone—ulcerative colitis	4.32e-05	0.000564	CcSEcCtD
Deferoxamine—Nausea—Dexamethasone—ulcerative colitis	4.31e-05	0.000562	CcSEcCtD
Deferoxamine—Nausea—Betamethasone—ulcerative colitis	4.31e-05	0.000562	CcSEcCtD
Deferoxamine—Dizziness—Prednisone—ulcerative colitis	4.18e-05	0.000545	CcSEcCtD
Deferoxamine—Vomiting—Prednisone—ulcerative colitis	4.02e-05	0.000524	CcSEcCtD
Deferoxamine—Headache—Prednisone—ulcerative colitis	3.96e-05	0.000516	CcSEcCtD
Deferoxamine—Nausea—Prednisone—ulcerative colitis	3.75e-05	0.000489	CcSEcCtD
